Bristol-Myers Squibb Aktie
| 61,95USD | 2,47USD | 4,15% |
WKN: 850501 / ISIN: US1101221083
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 32 200 | 34 300 | 34 100 | 34 100 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1,44 | 1,35 | 1,32 | 1,42 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 33 262 | 27 273 | 31 770 | 29 780 | 0 |
| Summe Anlagevermögen | 76 052 | 69 547 | 63 389 | 62 823 | 0 |
| Summe Aktiva | 109 314 | 96 820 | 95 159 | 92 603 | 0 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 73 308 | 65 702 | 65 674 | 76 215 | 0 |
| Summe Eigenkapital | 36 006 | 31 118 | 29 485 | 16 388 | 0 |
| Summe Passiva | 109 314 | 96 820 | 95 159 | 92 603 | 0 |
Adresse
| Route 206 & Province Line Road, 08543 Princeton | |
| Telefon | +1 (609) 252-4621 |
| Internet | http://www.bms.com |
Management
|
Abed Al-Nasser Odeh
Manager |
|
Adam Lenkowsky
Chief Commercialization Officer & Executive VP |
|
Amanda Poole
Chief Human Resources Officer & Executive VP |
|
Amy Fallone
Secretary & Senior Vice President |
|
Cari Gallman
Chief Policy Officer, EVP & General Counsel |
|
Catalina Vargas
Chief Of Staff |
|
Chris Shibutani
Chief Strategy Officer & Executive Vice President |
|
Christopher S. Boerner
Chairman & Chief Executive Officer |
|
Cristian Massacesi
Chief Medical Officer, Head-Development & EVP |
|
David V. Elkins
Chief Financial Officer & Executive Vice President |
|
Deepak L. Bhatt
Independent Director |
|
Derica W. Rice
Independent Director |
|
Estelle Vester-Blokland
Senior VP-Global Medical Affairs |
|
Frank Incontrera
Director-Global Energy Services |
|
Greg Meyers
Chief Digital & Technology Officer |
|
Julia A. Haller
Independent Director |
|
Julie Rozenblyum
Senior Vice President-Business Development |
|
Karen H. Vousden
Independent Director |
|
Karin Shanahan
Executive VP-Global Product Development & Supply |
|
Kimberly McCutcheon Jablonski
Chief Compliance & Ethics Officer |
|
Manuel Hidalgo Medina
Independent Director |
|
Maria V. Lopez Bresnahan
Vice President |
|
Mark Rolfe
Senior Vice President |
|
Michael R. McMullen
Independent Director |
|
Nicholas Botwood
Head-Worldwide Medical Oncology |
|
Paula A. Price
Independent Director |
|
Peter J. Arduini
Independent Director |
|
Phil Holzer
Chief Accounting Officer, Senior VP & Controller |
|
Phyllis R. Yale
Independent Director |
|
Robert M. Plenge
Chief Research Officer, Head-Research & EVP |
|
Teresa M. Foy
Senior VP-Immuno Oncology & Cell Therapy |
|
Theodore Rapp Samuels
Lead Independent Director |
|
William Perhacs
Director-Global Energy & Sustainability Services |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.